Can a common steroid help cancer patients breathe easier?
NCT ID NCT03367156
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the steroid dexamethasone can reduce shortness of breath (dyspnea) in people with cancer. About 135 cancer patients with moderate to severe breathing difficulty took part. Researchers measured changes in their breathlessness over one to two weeks to see if the drug provides relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harris Health System Settegast Health Center
Houston, Texas, 77028, United States
-
Lyndon B. Johnson Hospital
Houston, Texas, 77026, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple breath: could guided breathing calm heart failure symptoms?
- Can a touch on the hands ease Asthma's breathlessness and sleeplessness?
- Can a Hand-Based therapy ease COPD's toughest symptoms?
- Blood test may one day personalize drug dosing after stem cell transplants
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- AI could sharpen emergency diagnoses for chest pain and breathing trouble